CA Stock MarketDetailed Quotes
BGA BioNeutra Global Corp
- 0.040
- 0.0000.00%
15min DelayMarket Closed Jul 17 16:00 ET
1.86MMarket Cap-800P/E (TTM)
0.000High0.000Low0Volume0.000Open0.040Pre Close0.00Turnover0.16052wk High0.00%Turnover Ratio46.45MShares0.00552wk Low-0.05EPS TTM1.18MFloat Cap0.950Historical HighLossP/E (Static)29.48MShs Float0.005Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM-0.26P/B1Lot Size--Div YieldTTM
BioNeutra Global Corp Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -17.88%2.46M | -15.00%11.38M | 4.51%2.7M | -22.89%2.53M | -12.22%3.15M | -23.77%2.99M | -13.05%13.39M | -39.51%2.58M | -13.83%3.29M | -11.47%3.59M |
| Operating revenue | -17.88%2.46M | -15.00%11.38M | 4.51%2.7M | -22.89%2.53M | -12.22%3.15M | -23.77%2.99M | -13.05%13.39M | -39.51%2.58M | -13.83%3.29M | -11.47%3.59M |
| Cost of revenue | -25.56%1.94M | -34.44%7.24M | -92.57%227.94K | -33.09%1.64M | 0.10%2.76M | -5.61%2.6M | -11.73%11.04M | -26.07%3.07M | -19.01%2.45M | 5.04%2.76M |
| Gross profit | 33.66%518.56K | 76.42%4.14M | 612.59%2.47M | 7.15%892.3K | -53.13%389.8K | -66.73%387.98K | -18.76%2.35M | -487.51%-482.41K | 6.20%832.74K | -41.84%831.73K |
| Operating expense | 2.86%1.17M | 15.91%5.58M | -34.01%1.01M | 53.89%2.01M | 29.78%1.42M | 29.58%1.14M | -8.21%4.82M | 121.09%1.54M | 7.26%1.31M | -27.45%1.09M |
| Selling and administrative expenses | 16.90%1.07M | 5.12%4.12M | 3.58%1.16M | -6.49%961.12K | 1.52%1.09M | 27.90%913.53K | -5.86%3.92M | 30.11%1.12M | 34.85%1.03M | -9.03%1.07M |
| -Selling and marketing expense | -3.44%119.68K | 178.34%393.69K | 769.27%74.18K | -20.71%56.88K | 49.61%138.7K | --123.94K | -67.40%141.44K | -110.68%-11.08K | 78.84%71.74K | -13.35%92.71K |
| -General and administrative expense | 20.10%948.26K | -1.36%3.73M | -3.98%1.09M | -5.43%904.23K | -3.05%947.51K | 10.55%789.59K | 1.29%3.78M | 49.37%1.13M | 32.40%956.12K | -8.60%977.27K |
| Research and development costs | 3.16%33.39K | 990.96%146.31K | -43.87%26.3K | 44.36%48.75K | --38.9K | 112.20%32.36K | -241.75%-16.42K | 204.57%46.86K | 153.10%33.77K | ---- |
| Depreciation amortization depletion | -0.27%55.34K | 12.93%227.05K | -36.57%56.78K | 43.23%56.7K | 65.36%58.08K | 50.70%55.49K | -36.10%201.06K | 129.93%89.53K | -85.31%39.59K | -85.47%35.12K |
| -Depreciation and amortization | -0.27%55.34K | 12.93%227.05K | -36.57%56.78K | 43.23%56.7K | 65.36%58.08K | 50.70%55.49K | -36.10%201.06K | 129.93%89.53K | -85.31%39.59K | -85.47%35.12K |
| Other operating expenses | -88.11%16.56K | 53.14%1.08M | -182.37%-230.32K | 360.34%943.39K | 1,735.28%232.59K | 22.26%139.24K | -6.00%708.42K | 57.73%279.61K | 18.65%204.93K | -119.62%-14.22K |
| Operating profit | 13.02%-654.65K | 41.69%-1.44M | 172.17%1.46M | -136.09%-1.12M | -295.91%-1.03M | -363.06%-752.63K | -4.73%-2.47M | -253.75%-2.02M | -9.19%-473.4K | -252.52%-259.15K |
| Net non-operating interest income (expenses) | -1.77%-174.37K | -28.77%-579.72K | 46.45%-76.24K | -43.46%-164.55K | -61.47%-167.6K | -91.77%-171.33K | -16.22%-450.21K | -50.91%-142.37K | -22.19%-114.7K | -1.49%-103.8K |
| Non-operating interest income | 41,973.68%31.98K | 110,759.43%117.51K | 173,994.92%102.72K | 38,828.57%13.63K | 12,055.56%1.09K | 2,433.33%76 | -96.75%106 | 2,850.00%59 | -98.92%35 | 80.00%9 |
| Non-operating interest expense | 20.38%206.34K | 54.83%697.23K | 25.64%178.95K | 55.29%178.17K | 62.51%168.7K | 91.85%171.41K | 15.28%450.32K | 50.97%142.43K | 18.14%114.73K | 1.49%103.81K |
| Other net income (expenses) | -332.89%-3.55K | -1,872.03%-89.55K | -98.95%9.99K | 91.69%-53.41K | 80.55%-45.32K | 98.98%-821 | 94.78%-4.54K | 6,323.77%952.26K | -173.78%-642.95K | -256.16%-233.01K |
| Gain on sale of security | -332.89%-3.55K | -321.94%-87.78K | -98.77%11.76K | 91.69%-53.41K | 80.55%-45.32K | 97.77%-821 | 145.45%39.55K | 6,323.77%952.26K | -173.78%-642.95K | -256.16%-233.01K |
| Special income (charges) | ---- | 95.99%-1.77K | ---1.77K | --0 | --0 | ---- | ---44.09K | --0 | --0 | --0 |
| -Less:Write off | ---- | --37.16K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | 180.26%35.39K | --35.39K | --0 | --0 | ---- | ---44.09K | --0 | --0 | --0 |
| Income before tax | 9.97%-832.58K | 27.86%-2.11M | 214.98%1.39M | -8.49%-1.34M | -107.89%-1.24M | -897.79%-924.78K | -3.25%-2.92M | -86.04%-1.21M | -61.50%-1.23M | -2,141.85%-595.95K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 9.97%-832.58K | 27.86%-2.11M | 214.98%1.39M | -8.49%-1.34M | -107.89%-1.24M | -897.79%-924.78K | -3.25%-2.92M | -86.04%-1.21M | -61.50%-1.23M | -2,141.85%-595.95K |
| Net income continuous operations | 9.97%-832.58K | 27.86%-2.11M | 214.98%1.39M | -8.49%-1.34M | -107.89%-1.24M | -897.79%-924.78K | -3.25%-2.92M | -86.04%-1.21M | -61.50%-1.23M | -2,141.85%-595.95K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 9.97%-832.58K | 27.86%-2.11M | 214.98%1.39M | -8.49%-1.34M | -107.89%-1.24M | -897.79%-924.78K | -3.25%-2.92M | -86.04%-1.21M | -61.50%-1.23M | -2,141.85%-595.95K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 9.97%-832.58K | 27.86%-2.11M | 214.98%1.39M | -8.49%-1.34M | -107.89%-1.24M | -897.79%-924.78K | -3.25%-2.92M | -86.04%-1.21M | -61.50%-1.23M | -2,141.85%-595.95K |
| Diluted earnings per share | 0.00%-0.02 | 16.67%-0.05 | 200.00%0.02 | 0.00%-0.03 | -200.00%-0.03 | -901.28%-0.02 | 0.00%-0.06 | -100.00%-0.02 | -50.00%-0.03 | -1,648.25%-0.01 |
| Basic earnings per share | 0.00%-0.02 | 16.67%-0.05 | 200.00%0.02 | 0.00%-0.03 | -200.00%-0.03 | -901.28%-0.02 | 0.00%-0.06 | -100.00%-0.02 | -50.00%-0.03 | -1,648.25%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg